Institute for Translational Oncology Research, Greenville Health System — Greenville, South Carolina

Institute for Translational Oncology Research, Greenville Health System is a clinical research site located in Greenville, South Carolina, United States 29605.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Institute for Translational Oncology Research, Greenville Health System has participated in 1 clinical trials.

Therapeutic areas: Advanced Gastrointestinal Cancer.

Sponsors: Sumitomo Pharma America, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Institute for Translational Oncology Research, Greenville Health System?

Institute for Translational Oncology Research, Greenville Health System has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Institute for Translational Oncology Research, Greenville Health System conducted?

Institute for Translational Oncology Research, Greenville Health System has 1 clinical trials on record. Their work covers Advanced Gastrointestinal Cancer.

Is Institute for Translational Oncology Research, Greenville Health System accredited by Crixeo Health?

Institute for Translational Oncology Research, Greenville Health System has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Institute for Translational Oncology Research, Greenville Health System?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.